The 18 signatories emphasized that the moratorium wouldn't constitute a ban or include gene editing for research or treatment of diseases, but called on nations to develop a framework to govern the practice.
These two announcements come after Deborah DiSanzo left her role as IBM Watson Health general manager last year.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In a deal worth up to $25 million for ViaCyte, the companies will work together to create allogeneic stem cell therapies to treat the disease.
In the ongoing CRISPR Cas9 gene-editing technology, the Broad Institute suffered a major blow in Europe with each side exploiting the idiosyncrasies of national patent laws in Europe and in the U.S.
The Broad Institute plans to develop and roll out GATK4, the next generation version of Genome Analysis Toolkit. The new service will include cancer, structural variation, copy number variation and related functionality.
Transposagen, a Kentucky biotech that develops research tools and animal models for drug discovery, will add CRISPR technology to its existing suite of gene editing tools.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Former Biogen R&D chief Doug Williams is launching a biotech startup called Codiak BioSciences with $80 million. It is developing exosomes as a new diagnostic and therapeutic tool, beginning with pancreatic cancer.